Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by HuntNGatheron Mar 19, 2011 11:52am
572 Views
Post# 18310237

The Eye of The Storm

The Eye of The StormIt is exciting to see that people are excited again.
It was only a year ago when the snow was melting and the days were getting longer that we were preparing for our 'big news'.

The big tornado was coming in the spring and we knew it.  As the interest built, we all got a little richer on paper.  Then the leading edge of the storm hit two waves.  The stop-loss day at the AGM when many were crushed, then rebuilt. 
Finally, the big day when them leading edge of the storm hit and we saw 45s turn into 10s and then into 5s.

It broke many, both emotionally and financially.  Some were gone forever and would never look back.

Others sat as the eye of the storm moved overtop and we sat transfixed, looking for hope...looking for something to indicate whether we should pile on even more, stand still or jump.

There wasn't much to talk about because some of the players changed and the money was trickling away but the facts stayed pretty much the same.

-Then came the boost of a refreshed Board led by someone who put his own money down to buy his way onto the big chair showing us that this was not research team that happened to have a business... THIS was a business doing research.
-Then came November and reanalysis of results.
-Then came the special meeting to remind the faithful why we were still here and what was accomplished and that there were many lessons learned in P2B and a new path forward was being cleared to do it right the next time.
-Then came the warrants, the US Military, the MS Story rising up, the TBI story rising up,  the FDA early indications of positive news
-Not to mention the patent protections that are the lifeblood of this and any biotech/biopharma.

And now, as of Friday, I do believe the calm eye of the storm has moved behind us.  We are just about to come out the other side and it will be a wild whip.

Once again, the same decisions rise up.

Pile on?  Stand Still?  Jump?

Tough call but I paid for the whole ride and I am not getting off.

HnG
Bullboard Posts